Image HATICE EROL/PIXABAY Did The US Jump The Gun With The New Omicron-Targeted Vaccines? Op-ed calls for more information about cost versus benefit as vaccine-makers prepare to hike prices. Sep 13, 2022 Subscribe to marketing